Skip to main content

Table 3 Predictors of re-hospitalizations in single-factor logistic regression

From: The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy – 5-year follow-up

Categorical variable

With re-hospitalization (%)

Without re-hospitalization (%)

p

leg edema

91

9

0.009

hepatomegaly

88

11

0.03

No beta-blocker therapy

98

0

0.006

Quantitative variable

With re-hospitalization (median; Q25–Q75)

Without re-hospitalization (median; Q25–Q75)

p

BMI 2*

25; 24–30

30; 26–32

0.04

NT-proBNP 1

1848; 931–3248

895; 511–2026

0.02

NT-proBNP 2

1852; 775–4000

745; 360–1680

0.005

LVEF 1

27; 22–31

33; 28–38

0.02

LVEF 2

30; 24–32

34; 29–40

0.02

LVsD 2

6; 5.2–6.4

5.3; 4.4–5.6

0.001

MR 1

1.5; 1–2

1; 0–1

0.03

MR 2

1; 1–2

1; 0–1

0.03

6-MWT 1

350; 290–405

438; 350–490

0.01

6-MWT 2

370; 290–450

480; 395–595

0.001

  1. *1 – for variables assessed after inclusion; 2 – for variables assessed after 2 months.
  2. Q25–Q75: quartiles 25% and 75%.
  3. ABBREVIATIONS: BMI body mass index; NT-proBNP N-terminal pro-brain natriuretic peptide; LVEF left ventricular ejection fraction; LVsD left ventricular systolic diameter; MR mitral regurgitation; 6 MWT 6 minute walk test.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X